Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries

Table 1

Number of clinical trials with patients with cancer by phase of development.

Country	Phase 1	Phase 1/2	Phase 1/3	Phase 2	Phase 2/3	Phase 3	Phase 3/4	Phase 4	Not Stated	Total
Argentina	1	0	0	7	0	35	0	0	1	44
Brazil	1	2	1	6	0	33	0	2	2	47
Chile	0	0	1	1	0	16	0	1	0	19
China	21	21	0	83	13	63	0	34	19	257
Colombia	0	0	0	3	0	15	0	1	0	19
Denmark	5	5	0	26	1	26	0	4	0	67
Egypt	0	0	0	2	1	10	1	2	0	16
Estonia	0	0	0	2	0	8	0	0	0	10
Finland	1	2	0	8	0	17	0	5	0	33
France	19	14	0	40	3	37	0	3	0	116
Germany	13	8	0	44	5	34	0	3	5	112
India	5	1	1	6	3	27	2	12	20	77
Iran	1	1	0	9	5	6	0	0	7	29
Israel	3	7	0	18	0	43	0	1	0	72
Italy	2	8	1	38	1	34	0	2	1	87
Japan	17	7	0	35	1	13	0	2	12	87
Malaysia	0	0	0	4	1	16	2	1	0	24
Mexico	1	1	1	5	0	38	0	2	0	48
Netherlands	30	25	1	48	1	57	0	13	2	177
Peru	1	0	0	2	0	17	0	0	0	20
Philippines	0	0	1	4	1	25	0	1	0	32
Russia	2	4	1	19	2	51	1	2	0	82
Singapore	8	15	0	19	1	24	0	1	1	69
South Africa	0	0	1	0	0	23	1	0	0	25
South Korea	18	7	1	21	2	27	0	3	7	86
Spain	17	14	1	28	2	36	0	1	0	99
Thailand	2	4	0	11	1	30	2	3	0	53
Turkey	0	1	1	2	0	33	1	0	0	38
Ukraine	2	3	1	3	1	29	0	0	1	40
United K.	24	12	0	32	3	33	0	1	6	111
United States	170	59	1	123	3	35	0	4	32	427